
Pain Management Drugs Industry Research Report 2024
Description
Pain Management Drugs Industry Research Report 2024
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
Highlights
The global Pain Management Drugs market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Management Drugs.
The Pain Management Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Management Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Product Type Insights
Global markets are presented by Pain Management Drugs type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Pain Management Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Pain Management Drugs segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Pain Management Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pain Management Drugs market.
Pain Management Drugs Segment by Application
Hospitals
Drugstores
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pain Management Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pain Management Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
95 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Pain Management Drugs by Type
- 2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
- 1.2.2 Generic Opioids
- 1.2.3 Branded Opioids
- 1.2.4 NSAIDs
- 1.2.5 Others
- 2.3 Pain Management Drugs by Application
- 2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
- 2.3.2 Hospitals
- 2.3.3 Drugstores
- 2.3.4 Others
- 2.4 Assumptions and Limitations
- 3 Pain Management Drugs Breakdown Data by Type
- 3.1 Global Pain Management Drugs Historic Market Size by Type (2019-2024)
- 3.2 Global Pain Management Drugs Forecasted Market Size by Type (2025-2030)
- 4 Pain Management Drugs Breakdown Data by Application
- 4.1 Global Pain Management Drugs Historic Market Size by Application (2019-2024)
- 4.2 Global Pain Management Drugs Forecasted Market Size by Application (2019-2024)
- 5 Global Growth Trends
- 5.1 Global Pain Management Drugs Market Perspective (2019-2030)
- 5.2 Global Pain Management Drugs Growth Trends by Region
- 5.2.1 Global Pain Management Drugs Market Size by Region: 2019 VS 2023 VS 2030
- 5.2.2 Pain Management Drugs Historic Market Size by Region (2019-2024)
- 5.2.3 Pain Management Drugs Forecasted Market Size by Region (2025-2030)
- 5.3 Pain Management Drugs Market Dynamics
- 5.3.1 Pain Management Drugs Industry Trends
- 5.3.2 Pain Management Drugs Market Drivers
- 5.3.3 Pain Management Drugs Market Challenges
- 5.3.4 Pain Management Drugs Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Pain Management Drugs Players by Revenue
- 6.1.1 Global Top Pain Management Drugs Players by Revenue (2019-2024)
- 6.1.2 Global Pain Management Drugs Revenue Market Share by Players (2019-2024)
- 6.2 Global Pain Management Drugs Industry Players Ranking, 2022 VS 2023 VS 2024
- 6.3 Global Key Players of Pain Management Drugs Head office and Area Served
- 6.4 Global Pain Management Drugs Players, Product Type & Application
- 6.5 Global Pain Management Drugs Players, Date of Enter into This Industry
- 6.6 Global Pain Management Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Pain Management Drugs Market Size (2019-2030)
- 7.2 North America Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 7.3 North America Pain Management Drugs Market Size by Country (2019-2024)
- 7.4 North America Pain Management Drugs Market Size by Country (2025-2030)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Pain Management Drugs Market Size (2019-2030)
- 8.2 Europe Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 8.3 Europe Pain Management Drugs Market Size by Country (2019-2024)
- 8.4 Europe Pain Management Drugs Market Size by Country (2025-2030)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Pain Management Drugs Market Size (2019-2030)
- 9.2 Asia-Pacific Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 9.3 Asia-Pacific Pain Management Drugs Market Size by Country (2019-2024)
- 9.4 Asia-Pacific Pain Management Drugs Market Size by Country (2025-2030)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Pain Management Drugs Market Size (2019-2030)
- 10.2 Latin America Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 10.3 Latin America Pain Management Drugs Market Size by Country (2019-2024)
- 10.4 Latin America Pain Management Drugs Market Size by Country (2025-2030)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Pain Management Drugs Market Size (2019-2030)
- 11.2 Middle East & Africa Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
- 11.3 Middle East & Africa Pain Management Drugs Market Size by Country (2019-2024)
- 11.4 Middle East & Africa Pain Management Drugs Market Size by Country (2025-2030)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 GSK
- 11.1.1 GSK Company Detail
- 11.1.2 GSK Business Overview
- 11.1.3 GSK Pain Management Drugs Introduction
- 11.1.4 GSK Revenue in Pain Management Drugs Business (2017-2022)
- 11.1.5 GSK Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Detail
- 11.2.2 Pfizer Business Overview
- 11.2.3 Pfizer Pain Management Drugs Introduction
- 11.2.4 Pfizer Revenue in Pain Management Drugs Business (2017-2022)
- 11.2.5 Pfizer Recent Development
- 11.3 Grunenthal
- 11.3.1 Grunenthal Company Detail
- 11.3.2 Grunenthal Business Overview
- 11.3.3 Grunenthal Pain Management Drugs Introduction
- 11.3.4 Grunenthal Revenue in Pain Management Drugs Business (2017-2022)
- 11.3.5 Grunenthal Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Detail
- 11.4.2 Sanofi Business Overview
- 11.4.3 Sanofi Pain Management Drugs Introduction
- 11.4.4 Sanofi Revenue in Pain Management Drugs Business (2017-2022)
- 11.4.5 Sanofi Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Company Detail
- 11.5.2 Bayer Business Overview
- 11.5.3 Bayer Pain Management Drugs Introduction
- 11.5.4 Bayer Revenue in Pain Management Drugs Business (2017-2022)
- 11.5.5 Bayer Recent Development
- 11.6 AstraZeneca
- 11.6.1 AstraZeneca Company Detail
- 11.6.2 AstraZeneca Business Overview
- 11.6.3 AstraZeneca Pain Management Drugs Introduction
- 11.6.4 AstraZeneca Revenue in Pain Management Drugs Business (2017-2022)
- 11.6.5 AstraZeneca Recent Development
- 11.7 Eli Lilly
- 11.7.1 Eli Lilly Company Detail
- 11.7.2 Eli Lilly Business Overview
- 11.7.3 Eli Lilly Pain Management Drugs Introduction
- 11.7.4 Eli Lilly Revenue in Pain Management Drugs Business (2017-2022)
- 11.7.5 Eli Lilly Recent Development
- 11.8 Endo
- 11.8.1 Endo Company Detail
- 11.8.2 Endo Business Overview
- 11.8.3 Endo Pain Management Drugs Introduction
- 11.8.4 Endo Revenue in Pain Management Drugs Business (2017-2022)
- 11.8.5 Endo Recent Development
- 11.9 Merck
- 11.9.1 Merck Company Detail
- 11.9.2 Merck Business Overview
- 11.9.3 Merck Pain Management Drugs Introduction
- 11.9.4 Merck Revenue in Pain Management Drugs Business (2017-2022)
- 11.9.5 Merck Recent Development
- 11.10 Yunnan Baiyao
- 11.10.1 Yunnan Baiyao Company Detail
- 11.10.2 Yunnan Baiyao Business Overview
- 11.10.3 Yunnan Baiyao Pain Management Drugs Introduction
- 11.10.4 Yunnan Baiyao Revenue in Pain Management Drugs Business (2017-2022)
- 11.10.5 Yunnan Baiyao Recent Development
- 11.11 Teikoku Seiyaku
- 11.11.1 Teikoku Seiyaku Company Detail
- 11.11.2 Teikoku Seiyaku Business Overview
- 11.11.3 Teikoku Seiyaku Pain Management Drugs Introduction
- 11.11.4 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2017-2022)
- 11.11.5 Teikoku Seiyaku Recent Development
- 11.12 Teva
- 11.12.1 Teva Company Detail
- 11.12.2 Teva Business Overview
- 11.12.3 Teva Pain Management Drugs Introduction
- 11.12.4 Teva Revenue in Pain Management Drugs Business (2017-2022)
- 11.12.5 Teva Recent Development
- 11.13 J&J
- 11.13.1 J&J Company Detail
- 11.13.2 J&J Business Overview
- 11.13.3 J&J Pain Management Drugs Introduction
- 11.13.4 J&J Revenue in Pain Management Drugs Business (2017-2022)
- 11.13.5 J&J Recent Development
- 11.14 Assertio Therapeutics
- 11.14.1 Assertio Therapeutics Company Detail
- 11.14.2 Assertio Therapeutics Business Overview
- 11.14.3 Assertio Therapeutics Pain Management Drugs Introduction
- 11.14.4 Assertio Therapeutics Revenue in Pain Management Drugs Business (2017-2022)
- 11.14.5 Assertio Therapeutics Recent Development
- 11.15 Allergan
- 11.15.1 Allergan Company Detail
- 11.15.2 Allergan Business Overview
- 11.15.3 Allergan Pain Management Drugs Introduction
- 11.15.4 Allergan Revenue in Pain Management Drugs Business (2017-2022)
- 11.15.5 Allergan Recent Development
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.